(November 12, 2010 – BUSINESS WIRE) — Arrayit Corporation (OTCBB: ARYC) sold a third advanced microarray manufacturing system to the University of Texas Southwestern Medical Center at Dallas. The NanoPrint LM60 Microarrayer equipped with Arrayit’s Patented Microarray Manufacturing Technology is a computer-driven robotic microarray manufacturing system that enables the screening of 1.5 million lead therapeutic compounds per run, and the NanoPrint LM210 enables more than 5 million.

UT Southwestern will use the NanoPrint LM60 to screen large libraries of potential therapeutic small molecules involved in cancer and heart disease. These small molecules have advantageous stability and biological activity, are suitable for drug delivery, and are easily manufactured in large, diverse libraries, making them attractive for therapeutic use. Read more about nanotechnology in medicine in our Life Sciences and Medical Technology center.

The use of Arrayit’s technology and UT Southwestern’s systematic approach has already led to the discovery of specific compounds known to be involved in cancer and cardiovascular disease.

Once an Arrayit manufacturing platform is installed, UT Southwestern can purchase an ongoing supply of proprietary consumable products for applications in small-molecule high-throughput screening, gene expression, multiplexed immunoassays, cytogenetics and more.

The company’s proprietary microarray manufacturing technology has been installed at more than 3,800 institutions worldwide, including 27 in Texas.

Arrayit Corporation supplies proprietary life science technologies and consumables for disease prevention, treatment and cure to genetic, research, pharmaceutical, and diagnostic sectors. Please visit www.arrayit.com for more information.

Follow Small Times on Twitter.com by clicking www.twitter.com/smalltimes. Or join our Facebook group